SEMA7A-ITGB1 axis plays pivotal roles for EGFR-TKI resistance in human EGFR mutant lung cancer

被引：0
|
作者：
Kinehara, Yuhei [1 ,2 ]
Nagatomo, Izumi [1 ]
Kijima, Takashi [3 ]
Kumanogoh, Atsushi [1 ]
机构：
[1] Osaka Univ, Dept Resp Med Immunol, Suita, Osaka, Japan
[2] Hosp Nissay, Osaka, Japan
[3] Hyogo Coll Med, Div Resp Med, Nishinomiya, Hyogo, Japan
来源：
CANCER SCIENCE | 2018年 / 109卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
J-3044
引用
收藏
页码：1185 / 1185
页数：1
相关论文
共 50 条
  • [1] Semaphorin 7A promotes EGFR-TKI resistance in EGFR mutant lung adenocarcinoma cells
    Kinehara, Yuhei
    Nagatomo, Izumi
    Koyama, Shohei
    Ito, Daisuke
    Nojima, Satoshi
    Kurebayashi, Ryota
    Nakanishi, Yoshimitsu
    Suga, Yasuhiko
    Nishijima-Futami, Yu
    Osa, Akio
    Nakatani, Takeshi
    Kato, Yasuhiro
    Nishide, Masayuki
    Hayama, Yoshitomo
    Higashiguchi, Masayoshi
    Morimura, Osamu
    Miyake, Kotaro
    Kang, Sujin
    Minami, Toshiyuki
    Hirata, Haruhiko
    Iwahori, Kota
    Takimoto, Takayuki
    Takamatsu, Hyota
    Takeda, Yoshito
    Hosen, Naoki
    Hoshino, Shigenori
    Shintani, Yasushi
    Okumura, Meinoshin
    Kumagai, Toru
    Nishino, Kazumi
    Imamura, Fumio
    Nakatsuka, Shin-ichi
    Kijima, Takashi
    Kida, Hiroshi
    Kumanogoh, Atsushi
    JCI INSIGHT, 2018, 3 (24):
  • [2] Overcoming EGFR-TKI resistance in EGFR-mutated lung cancer
    Gardizi, M.
    Scheffler, M.
    Bos, M.
    Geist, T.
    Heukamp, L.
    Nogova, L.
    Toepelt, K.
    Fernandez-Cuesta, L.
    Culmann, H.
    Kaminsky, B.
    Panse, J.
    Becker, C.
    Mattonet, C.
    Serke, M.
    Schmitz, S.
    Schnell, R.
    Galetke, W.
    Hekmat, K.
    Buettner, R.
    Wolf, J.
    ONKOLOGIE, 2013, 36 : 30 - 30
  • [3] SLK Causes Resistance to EGFR-TKI in Lung Cancer
    Ashraf, K.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2371 - S2372
  • [4] Apatinib combined with EGFR-TKI in treating advanced non-small cell lung cancer with EGFR-TKI resistance
    Tian, R.
    Guo, W.
    Guo, Y.
    Zhang, X.
    Zhu, H.
    Shen, F.
    Xu, J.
    Zhang, X.
    Wang, R.
    Ren, X.
    Li, J.
    Song, X.
    ANNALS OF ONCOLOGY, 2019, 30
  • [5] Mechanisms of EGFR-TKI induced cell death and resistance in EGFR mutant non-small cell lung cancer
    Ko, J.
    Kim, Y.
    Park, M.
    Cui, Z.
    Ahn, M.
    Park, K.
    EJC SUPPLEMENTS, 2008, 6 (09): : 29 - 30
  • [6] MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis
    Li, Y-L
    Liu, X-M
    Zhang, C-Y
    Zhou, J-B
    Shao, Y.
    Liang, C.
    Wang, H-M
    Hua, Z-Y
    Lu, S-D
    Ma, Z-L
    ONCOGENESIS, 2017, 6 : e372 - e372
  • [7] MicroRNA-34a/EGFR axis plays pivotal roles in lung tumorigenesis
    Y-L Li
    X-M Liu
    C-Y Zhang
    J-B Zhou
    Y Shao
    C Liang
    H-M Wang
    Z-Y Hua
    S-D Lu
    Z-L Ma
    Oncogenesis, 2017, 6 : e372 - e372
  • [8] EGFR-TKI rechallenged treatment combined with apatinib in non-small cell lung cancer with EGFR-TKI resistance.
    Liang, Li
    Li, Fang
    Cao, Baoshan
    Zhang, Zhaohui
    Zhu, Xiang
    Wang, Jiadong
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [9] Efficacy and safety of apatinib plus EGFR-TKI in advanced non-small cell lung cancer with EGFR-TKI resistance
    Tian, R.
    ANNALS OF ONCOLOGY, 2021, 32 : S980 - S981
  • [10] EGFR-TKI rechallenge with bevacizumab in EGFR-mutant non-small cell lung cancer
    Kyoko Otsuka
    Akito Hata
    Jumpei Takeshita
    Chiyuki Okuda
    Reiko Kaji
    Katsuhiro Masago
    Shiro Fujita
    Nobuyuki Katakami
    Cancer Chemotherapy and Pharmacology, 2015, 76 : 835 - 841
12345